1h Free Analyst Time
The heparin market is forecasted to grow by USD 3.59 billion during 2024-2029, accelerating at a CAGR of 7.3% during the forecast period. The report on the heparin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of coagulation disorders, growing prevalence of chronic conditions, and reintroduction of alternative sources to produce heparin.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The heparin market is segmented as below:
By Product
- LMWH
- Others
By Route Of Administration
- Subcutaneous injection
- Intravenous infusion
By Source
- Porcine
- Bovine
- Synthetic
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
The report on the heparin market covers the following areas:
- Heparin Market sizing
- Heparin Market forecast
- Heparin Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Route of Administration
10 Market Segmentation by Source
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global heparin market: Aspen Pharmacare Holdings Ltd., B.Braun SE, Baxter International Inc., Eisai Co. Ltd., Fresenius SE and Co. KGaA, Hebei Changshan Biochemical, Hikma Pharmaceuticals Plc, Laboratorios Farmaceuticos ROVI S A, LEO Pharma AS, Nanjing Kingfriend Biochemical, Opocrin SpA, Pfizer Inc., Sanofi SA, Shanghai Fosun Pharmaceutical Group Co. Ltd., Shenzhen Techdow Pharmaceutical, Teva Pharmaceutical Industries Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing research and development activities and new therapeutic applications of heparin."
According to the report, one of the major drivers for this market is the increasing prevalence of coagulation disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aspen Pharmacare Holdings Ltd.
- B.Braun SE
- Baxter International Inc.
- Eisai Co. Ltd.
- Fresenius SE and Co. KGaA
- Hebei Changshan Biochemical
- Hikma Pharmaceuticals Plc
- Laboratorios Farmaceuticos ROVI S A
- LEO Pharma AS
- Nanjing Kingfriend Biochemical
- Opocrin SpA
- Pfizer Inc.
- Sanofi SA
- Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Shenzhen Techdow Pharmaceutical
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
